Study guide

8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage

NCRA Oncology Data Specialist ODS-C

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters

1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish

2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws

2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority

3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance

3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance

4 Chapter 4: Registry Organization, Staffing & Information Systems

4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning

5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement

5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)

6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality

6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)

7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics

7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data

8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer

8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors

9 Chapter 9: Casefinding & Reportability

9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"

10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators

10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More

11 Chapter 11: Class of Case, Key Dates & Case Identifiers

11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them

12 Chapter 12: Follow-Up, Vital Status & Recurrence

12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary

13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade

13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables

14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules

14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules

15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018

15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples

16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS

16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation

8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage

Key Takeaways Explain This Topic AI

Carcinomas arise from epithelium (squamous, glandular or urothelial), sarcomas from connective tissue, and lymphomas and leukemias from blood-forming and lymphoid cells.

Hollow digestive organs have four main layers (mucosa, submucosa, muscularis propria, and serosa or adventitia); the deepest layer a tumor invades usually sets the T category.

The right lung has three lobes (upper, middle, lower) and the left lung two (upper, including the lingula, and lower); the colon runs cecum, ascending, hepatic flexure, transverse, splenic flexure, descending, sigmoid, then rectosigmoid junction and rectum.

Regional lymph nodes are defined for each site: breast drains mainly to axillary nodes, colon to pericolic and mesenteric nodes, lung to intrapulmonary, hilar and mediastinal nodes, and prostate and bladder to pelvic nodes.

Paired organs such as the breasts, lungs, kidneys, ovaries and testes require laterality coding, and bilateral tumors must go through the multiple primary rules.

Last updated: September 2026

Why anatomy is a separate blueprint topic

"Human anatomy and physiology" is one of the most highly rated knowledge statements in NCRA's 2022 role delineation study, and Route 3 candidates must have completed two semesters of it. On the exam, anatomy rarely appears as "name this bone." Instead it appears inside coding questions: which subsite, which wall layer, which node group is regional, and which organs are paired.

Levels of organization and tissue types

Cells form tissues , tissues form organs , and organs form systems . The four basic tissues map directly onto cancer categories:

Tissue Examples Cancer family

Epithelial (lining and glandular) Skin, lining of the GI tract, airways and ducts; glands Carcinoma : squamous cell carcinoma from flat squamous epithelium, adenocarcinoma from glandular epithelium, urothelial carcinoma from the transitional lining of the urinary tract

Connective Bone, cartilage, fat, fibrous tissue, blood vessels Sarcoma (osteo-, chondro-, lipo-, fibro-, angio-)

Muscle Smooth (organ walls), skeletal, cardiac Leiomyosarcoma, rhabdomyosarcoma

Nervous Neurons, glial cells, nerve sheaths Gliomas (astrocytoma, glioblastoma), neuroblastoma, nerve sheath tumors

Blood-forming tissue in the bone marrow produces two lineages. The myeloid lineage gives rise to red cells, platelets, granulocytes and monocytes, so its cancers include AML, CML, MDS and MPN. The lymphoid lineage produces B, T and NK cells, so its cancers include lymphomas, lymphoid leukemias and plasma cell neoplasms. This lineage split underlies the Hematopoietic Manual (Section 14.4).

The wall of a hollow organ

Hollow organs of the digestive tract share a layered wall:

Mucosa: the epithelium, the lamina propria (supporting connective tissue) and the muscularis mucosae (a thin muscle layer).

Submucosa: connective tissue rich in blood vessels and lymphatics.

Muscularis propria: the main muscle coat, with inner circular and outer longitudinal layers.

Subserosa and serosa (the visceral peritoneum) where the organ is covered by peritoneum; adventitia where it is not, as in the thoracic esophagus and part of the rectum.

In colorectal cancer, Tis is confined to the mucosa, T1 invades the submucosa, T2 the muscularis propria, T3 the pericolorectal tissue through the muscularis propria, T4a the visceral peritoneum, and T4b adjacent organs. The bladder wall (urothelium, lamina propria, muscularis propria, perivesical fat) follows the same idea for Ta, T1, T2 and T3 (Section 15.5).

Key organ subsites

Organ Subsites and landmarks Coding notes

Colon and rectum Cecum (C18.0), appendix (C18.1), ascending (C18.2), hepatic flexure (C18.3), transverse (C18.4), splenic flexure (C18.5), descending (C18.6), sigmoid (C18.7); rectosigmoid junction (C19.9); rectum (C20.9) Endoscopic distance from the anal verge helps locate rectal and sigmoid tumors; the operation performed (for example, right hemicolectomy or low anterior resection) supports the site

Lung Main bronchus (C34.0), upper lobe (C34.1), middle lobe (C34.2, right lung only), lower lobe (C34.3) Right lung has 3 lobes; left lung has 2 (the lingula is part of the left upper lobe)

Breast Nipple (C50.0), central (C50.1), upper-inner (C50.2), lower-inner (C50.3), upper-outer (C50.4), lower-outer (C50.5), axillary tail (C50.6) Clock positions map to quadrants differently for the right and left breast; 12, 3, 6 and 9 o'clock lie on quadrant boundaries

Prostate Peripheral, transition and central zones; right and left sides Most adenocarcinomas arise in the peripheral zone, which lies next to the rectum and can be felt on digital rectal exam

Kidney Cortex and medulla (parenchyma, C64.9); renal pelvis (C65.9); Gerota's fascia around the kidney and perirenal fat Renal pelvis tumors are usually urothelial and are coded and staged separately from kidney parenchyma tumors

Bladder Trigone, dome, lateral, anterior and posterior walls, bladder neck, ureteric orifice, urachus (C67.0–C67.9) Multiple bladder subsites involved by one tumor use the overlapping code (C67.8)

Male genital Testis (C62), epididymis (C63.0), spermatic cord (C63.1), penis (C60), prostate (C61.9), seminal vesicle (C63.7) The testis is paired; cryptorchid (undescended) testis has its own subsite code

Lymphatic drainage and regional lymph nodes

Lymph from each organ drains to predictable node groups, and AJCC and Summary Stage define which of them are regional for each site. Nodes outside that list are distant (M1).

Primary site Regional nodes (examples) Commonly distant

Breast Ipsilateral axillary (levels I–III), internal mammary, supraclavicular Contralateral axillary or internal mammary, cervical

Colon Pericolic, along the named colic vessels, mesenteric Para-aortic, distant nodes

Lung Intrapulmonary, hilar (N1); ipsilateral mediastinal and subcarinal (N2); contralateral mediastinal or hilar, scalene, supraclavicular (N3) Nodes outside the thorax

Prostate Pelvic: hypogastric, obturator, internal and external iliac, sacral Common iliac and higher (M1a)

Bladder Perivesical, obturator, internal and external iliac, sacral (N1–N2); common iliac (N3) Nodes above the common iliac

Testis Retroperitoneal (para-aortic, interaortocaval, paracaval) Pelvic and inguinal nodes may be regional only after scrotal or inguinal surgery; the rules are in the AJCC chapter

Always check the chapter for the site. The same node group can be regional for one primary and distant for another.

Body cavities and serosal membranes

The peritoneum lines the abdominal cavity, pleura covers the lungs and pericardium surrounds the heart.

Malignant cells in pleural or peritoneal fluid often mean distant (M1) disease. How to code this is site-specific; for example, a malignant pleural effusion is M1a in lung cancer.

Retroperitoneal organs include the kidneys, adrenal glands, pancreas (mostly), the ascending and descending colon (partly) and the great vessels.

Physiology that shows up in abstracts

Hormone dependence: estrogen and progesterone drive many breast cancers (the basis of ER and PR testing and endocrine therapy), and androgens drive prostate cancer (the basis of androgen deprivation therapy).

Endocrine feedback: thyroid-stimulating hormone (TSH) stimulates thyroid cells, so suppressing it with thyroid hormone is recorded as hormone therapy for papillary and follicular thyroid cancer.

Tumor markers reflect tissue physiology: PSA from prostate epithelium, AFP and beta-hCG from germ cell tumors, CEA from gut epithelium.

Paired organs and laterality

Paired sites listed in STORE include the parotid and submandibular glands, tonsils, lungs, pleura, breasts, ovaries, fallopian tubes, testes, epididymides, kidneys, renal pelves, ureters, eyes, adrenal glands and the cerebral hemispheres, among others. Record Laterality for each. Bilateral tumors in paired organs are sent through the multiple primary rules . Laterality alone does not decide the number of primaries.

Loading diagram... Colon wall layers and T category